All articles tagged with #diabetes
A meta-analysis of six longitudinal studies across five countries shows average total testosterone in men fell about 54% from 1972 to 2019, a decline over 1% per year. While natural variation exists, the population-wide drop could signal broader health issues linked to obesity, diabetes, and environmental factors affecting male health, warranting further investigation.
Gallup’s 2026 Health & Well-Being Index shows 11% of U.S. adults currently use GLP-1 weight-loss drugs (up from 3% in 2024) and 15% have used them ever. Brand-name meds account for 68% of current use, with compounded versions rising to 19% as cost/insurance influence switching. Awareness of GLP-1s is 91%. The obesity rate has declined to 36.4% in 2026, while diabetes rates remain steady, suggesting GLP-1 uptake may be linked to obesity declines. About one-third of compounded users switched from brand-name, mainly for cost reasons. Data come from 5,065 adults surveyed May 28–June 5, 2026.
A doctor outlines four red-flag symptoms men often hide—enlarged but painless testicles, erectile dysfunction, urinary frequency, and fatigue/decreased sex drive—and explains they can indicate testicular cancer, vascular disease, diabetes, or low testosterone, making early reporting to a clinician crucial for better outcomes.
Erectile dysfunction may precede and signal underlying cardiovascular, metabolic, and hormonal issues, potentially serving as an early biomarker for cardiometabolic disease and prompting broader health screening rather than being viewed in isolation.
Diabetes often harms kidneys without noticeable symptoms. Experts urge controlling blood sugar and blood pressure, staying hydrated appropriately, eating a kidney-friendly diet with moderated protein and salt, staying physically active, quitting tobacco, limiting alcohol, and getting regular kidney screenings to catch problems early and prevent long-term damage.
A UK Biobank analysis found that people with a gene variant that makes them more likely to like onions also have a lower risk of type 2 diabetes and high blood pressure. Experts caution that onions alone are unlikely to prevent these conditions and that overall healthy eating patterns matter more; more research is needed to establish causation.
A surge of diabetes patients in Taiz, Yemen, are stopping prescribed medications to follow the controversial el-tayebat diet, promoted online by former Egyptian doctor Diaa el-Awadi. Doctors warn there is no scientific basis for the diet, and abruptly abandoning insulin or pills can trigger life-threatening complications like diabetic ketoacidosis. The diet’s spread is fueled by social media, economic hardship, and distrust of conventional medicine, while nutritionists emphasize the need for individualized, medically supervised care rather than restrictive, unproven regimens.
Hundreds of studies suggest daily coffee may protect against liver disease, lower the risk of Type 2 diabetes, and reduce Parkinson’s disease risk, with compounds like chlorogenic acid aiding insulin sensitivity and liver protection.
Four observational studies published in June 2026 suggest GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) may affect more than glucose and weight: roughly 30% lower odds of breast cancer in users, a weakened impulsivity-to-violence link linked to brain GLP-1 receptors, a possible bone-protective effect despite weight loss, and a significant drop in daily physical activity among users. None establish causation; findings require randomized trials and do not change current indications. Clinicians should emphasize exercise and bone health monitoring, and patients should not start/stop meds based on these early results. Larger prospective studies are needed to confirm these associations.
A heat wave can make it harder for the body to cool and stay hydrated, and several everyday medications can increase the risk of dehydration, dizziness, and heat illness. The article outlines drug classes to watch during hot weather, including diuretics, beta blockers, ACE inhibitors/ARBs, mental-health meds (antipsychotics, SSRIs, TCAs), ADHD stimulants, allergy/sleep aids like diphenhydramine, and diabetes medications (SGLT2 inhibitors, GLP-1 drugs, insulin). It emphasizes not stopping medications without a clinician, suggests a “hot day plan,” and advises hydration, avoiding peak heat, breaks in shade/AC, proper medication storage, and recognizing warning signs of heat stress or heat stroke requiring urgent care.
Experts warn that signs often blamed on low testosterone—such as reduced sex drive, low energy, and erectile dysfunction—can reflect other health issues like depression, sleep apnea, thyroid problems, anemia, or diabetes. With online testosterone replacement therapy on the rise, many men are prescribed testosterone without proven low levels (only about 12% of those prescribed actually have low T). A full medical evaluation is essential, as symptoms may stem from multiple conditions rather than low T alone.
A study analyzing taste and smell genes in over 160,000 UK adults finds that liking onions correlates with a variant in the OR2T6 smell receptor and associates with lower risk of type 2 diabetes and high blood pressure via Mendelian randomization; the approach aims to clarify diet–disease links but causality isn’t proven and replication in diverse groups is needed, with onions’ bioactive compounds a potential focus.
Recent small studies suggest three everyday items may help with diabetes-related health metrics: a two-day, high-oats diet lowered LDL cholesterol by about 10% with effects persisting weeks after, daily avocado intake for six months linked to a lower dietary glycemic load, and peppermint oil (100 μL daily for 20 days) reducing systolic blood pressure and resting heart rate in adults with elevated blood pressure. While intriguing, researchers note these are small, short-term trials with potential funding biases, so more robust research is needed before changing treatment recommendations.
A study presented at ENDO 2026 shows that many GLP-1 medications are paused and then resumed, with more than half who discontinue restarting within two years and 41.5% doing so within the first year. Discontinuation is linked to GI side effects and insurance/cost barriers, though newer medications and having an endocrinologist initiate treatment are associated with better persistence. The findings highlight the importance of staying on GLP-1 therapy for ongoing weight loss, blood sugar control, and protection against heart and kidney risks, while also underscoring the need for support to overcome barriers that lead to stopping treatment.
New analysis of the Diabetes Prevention Program (DPP) and its 21-year follow-up (DPPOS) found that a lifestyle intervention—low-fat, low-calorie diet plus at least 150 minutes of weekly activity—was more effective at reducing multimorbidity over two decades than metformin, which performed no better than placebo; among Medicare participants, 82% in the lifestyle group developed multiple chronic conditions versus 85% on metformin and 87% on placebo.